Delaware Christiana Care NCORP

特拉华州克里斯蒂娜护理 NCORP

基本信息

批准号：
10460173
负责人：
GREGORY A MASTERS
金额：
$ 173.04万
依托单位：
CHRISTIANA CARE HEALTH SERVICES, INC.
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-08-01 至 2025-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10460173
关键词：
Address Advisory Committees Advocate Affect Aftercare American College of Radiology Imaging Network American Society of Clinical Oncology Appointment Area Breast Cancer Center Cancer Control Cancer Control Research Caring Catchment Area Clinical Research Clinical Treatment Clinical Trials Collaborations Communities Community Clinical Oncology Program Community Hospitals Conduct Clinical Trials Delaware Development Eastern Cooperative Oncology Group Enrollment Ensure Evidence based practice Financial cost Funding Genetic Counseling Goals Grant Health Technology Healthcare Image Incidence Individual Investigation Investigational Drugs Leadership Malignant Neoplasms Maryland Minority Outreach Program Mission Morbidity - disease rate NCI Center for Cancer Research National Cancer Institute National Clinical Trials Network New Jersey Oncologist Oncology Palliative Care Participant Patients Pennsylvania Persons Physicians Positioning Attribute Principal Investigator Process Program Evaluation Protocols documentation Quality of Care Quality of life Rare Diseases Research Research Design Research Institute Research Personnel Resources System Time Travel Tumor Bank Underrepresented Populations Underserved Population Work base cancer care cancer clinical trial cancer health disparity cancer prevention cancer therapy care coordination care costs care delivery cost data management data quality early phase trial expectation forest health care service organization improved member mortality multidisciplinary organizational structure programs protocol development quality assurance routine care screening social factors treatment trial underserved minority uptake

项目摘要

Project Summary/Abstract Delaware/Christiana Care (CCHS) National Cancer Institute Oncology Research Program (NCORP) was originally funded as a Community Clinical Oncology Program (CCOP) in 1987, was funded as a NCI Community Cancer Centers Program (NCCCP) beginning in 2007 and continued participation as an NCORP in 2014 through the present. CCHS has been an exemplary contributor to all programs, frequently recognized for high accruals,stellar data quality and timeliness of submissions. Currently, CCHS participates in the ALLIANCE, ECOG- ACRIN, NRG, Wake Forest and Rochester cooperative groups with approximately 80 trials opened to accrual. Participation in CTSU and the CIRB is active and ongoing. Our catchment area includes all of Delaware and portions of New Jersey, northeastern Maryland and southeastern Pennsylvania. Our NCORP includes two affiliates, Beebe Health Care and Nanticoke Memorial, both located in southern Delaware. Our communities represents a popluation base in excess of 2 million people with extensive protocol entry potential. Under the leadership of Gregory Masters, M.D, Principal Investigator and Kandie Dempsey, DBA, MS, RN, OCN, Director, NCORP investigators and support professionals will continue to participate in NCTN core committees and leadership positions. Currently, our physician researchers are represented with appointments to 17 NCORP committees and 3 NCI Steering Committees (Breast, Gynecological and Imaging). Our mission is to continue accruals to both treatment and cancer control studies and to further develop Cancer Care Delivery Research (CCDR) participation which will build upon the intiatives set forth with our collaboration the NCI. Every patient at the Helen F. Graham Cancer Center & Research Institute (HFGCCRI) is evaluated for clinical trial participation. We anticipate dedicating at minimum 10% of our activities towards CCDR to include scientific investigation of the complexities of social factors, organizational structures and processes, health technologies, access to cancer care, quality and cost factors, disparties in our community. And will examine the feasibility of examining financial costs of care and health technology systems as part of the CCDR program. The overall impact of this grant will be to ensure continuation and stimulate expansion of NCORP activities, including treatment and cancer control research, at CCHS and its affiliates. The Delaware/CCHS NCORP has consistently rated amongst top in the nation for clinical trial accruals. Over the past three years the accrual rate has been 21.1% in 2015, 26.3% in 2016 and 27.4% in 2017.

项目摘要/摘要特拉华州/克里斯蒂安娜（CCHS）国家癌症研究所肿瘤研究计划（NCORP）最初是在1987年作为社区临床肿瘤学计划（CCOP）资助的，从2007年开始作为NCI社区癌症中心计划（NCCCP）资助， 2014年通过当前继续参加NCORP。 CCHS一直是所有计划的示例性贡献者，经常以高额计费，出色的数据认可提交的质量和及时性。目前，CCHS参加了联盟，ECOG- Acrin，NRG，Wake Forest和Rochester合作团体，大约80次试验开放到应计。参与CTSU和CIRB是活跃的。我们的集水区地区包括特拉华州的所有和新泽西州，马里兰州东北部的部分地区宾夕法尼亚州东南部。我们的NCORP包括两个分支机构，Beebe Health Care和 Nanticoke Memorial，均位于特拉华州南部。我们的社区代表 popluation基地超过200万人，具有广泛的协议进入潜力。在 Gregory Masters，M.D，首席研究员的领导和坎迪·登普西（Kandie Dempsey），DBA，MS，RN， OCN，NCORP调查人员和支持专业人员的主任将继续参加 NCTN核心委员会和领导职务。目前，我们的医师研究人员是代表17个NCORP委员会和3个NCI转向委员会的任命（乳房，妇科和成像）。我们的使命是继续进行治疗和癌症控制研究并进一步发展癌症护理递送研究（CCDR）参与将建立在我们合作NCI的基础上。每一个 Helen F. Graham癌症中心与研究所（HFGCCRI）的患者进行了评估临床试验参与。我们预计至少要奉献10％的活动 CCDR包括对社会因素复杂性的科学研究，组织结构和过程，健康技术，获得癌症护理，质量和成本因素，我们社区中的分散。并将检查检查护理财务成本的可行性和卫生技术系统作为CCDR计划的一部分。这笔赠款的总体影响将确保继续并刺激NCORP活动的扩展，包括治疗以及CCHS及其分支机构的癌症控制研究。特拉华州/CCHS NCORP 始终被评为全国临床试验应计的顶级。在过去的三年中 2015年的应计比率为21.1％，2016年为26.3％，2017年为27.4％。